Moreover, Dox-loaded Apt-Td induced a significantly higher cytotoxicity to MUC1-positive cancer cells versus MUC1-negative control cells (Figure 6 & 7), indicating that Apt-Td achieved targeted drug delivery to MUC1-positive tumor cells in vitro. This evidence concerns the gene MUC1 and cancer.